Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Part 1: Hepatitis C (23 mins)

Learn about HCV testing and treatment strategies to promote HCV elimination.
Paul Y. Kwo, MD
Program Director
Manal F. Abdelmalek, MD, MPH
Oluwaseun Falade-Nwulia, MBBS, MPH
Released: December 17, 2019 Expiration: No longer available for credit

This program is divided into several short segments which you can step through using the Video Chapters widget.
PreviousNext

Related Content

Expert commentary from CCO on how providers can act as advocates for increased access to HCV care for persons who use drugs and incarcerated individuals

Oluwaseun Falade-Nwulia, MBBS, MPH Released: December 18, 2019

Watch this video from a live symposium for expert guidance on approaches to improve diagnosis and treatment of HCV, HBV, and NASH.

Paul Y. Kwo, MD
Program Director
Manal F. Abdelmalek, MD, MPH Oluwaseun Falade-Nwulia, MBBS, MPH
Physicians: maximum of 1.5 AMA PRA Category 1 Credits US Physicians: maximum of 1.5 Medical Knowledge MOC point(s) Released: December 17, 2019 Expired: No longer available for credit

HCV elimination approaches: Slides from the Clinical Care Options Symposium at the liver meeting 2019, with Oluwaseun Falade-Nwulia, MBBS, MPH

Oluwaseun Falade-Nwulia, MBBS, MPH Released: November 11, 2019

Expert commentary on the importance of improving HCV treatment uptake in persons who inject drugs and effective linkage-to-care strategies

Oluwaseun Falade-Nwulia, MBBS, MPH Released: October 14, 2019

Video Chapters


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue